Ann: Michigan Children Hospital commence first patients on wheezo, page-3

This is a slam dunk congratulations Respiri team!
Every key stakeholder has signed off and approved wheezo from the physicians who believe in it's function and value to the patient and some of the toughest and stingiest healthcare payors in the world confirming the cost benefit utilisation of RPM with wheezo in a hospital setting for children.
No need for any more studies or trials , straight to implementation !!
If management and advisors cannot leverage this with the investment community to significantly move the share price north of 5 cents then that is the company's weak spot and needs urgent action.